skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 6,785  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Database: Taylor & Francis Open Access remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Material Type:
Article
Add to My Research

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease

Vascular health and risk management, 2016-01, Vol.12 (Issue 1), p.171-183 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Toth. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S104369 ;PMID: 27226718

Full text available

2
A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?
Material Type:
Article
Add to My Research

A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?

Vascular health and risk management, 2023-01, Vol.19, p.237-253 [Peer Reviewed Journal]

2023 Diab et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Diab et al. 2023 Diab et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S379874 ;PMID: 37113563

Full text available

3
A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease
Material Type:
Article
Add to My Research

A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease

Vascular health and risk management, 2016-01, Vol.12 (Issue 1), p.85-103 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Maeder et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S74703 ;PMID: 27051291

Full text available

4
The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health
Material Type:
Article
Add to My Research

The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health

Gut microbes, 2021-01, Vol.13 (1), p.1-24 [Peer Reviewed Journal]

2021 The Author(s). Published with license by Taylor & Francis Group, LLC. 2021 ;2021 The Author(s). Published with license by Taylor & Francis Group, LLC. 2021 The Author(s) ;ISSN: 1949-0976 ;EISSN: 1949-0984 ;DOI: 10.1080/19490976.2021.1897212 ;PMID: 33764858

Full text available

5
Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis

Drug design, development and therapy, 2018-01, Vol.12, p.1685-1695 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Liu et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S166893 ;PMID: 29928112

Full text available

6
The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events
Material Type:
Article
Add to My Research

The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events

Platelets (Edinburgh), 2015-10, Vol.26 (7), p.680 [Peer Reviewed Journal]

EISSN: 1369-1635 ;DOI: 10.3109/09537104.2014.979340 ;PMID: 25549287

Digital Resources/Online E-Resources

7
Elevated Lipoprotein(a): Background, Current Insights and Future Potential Therapies
Material Type:
Article
Add to My Research

Elevated Lipoprotein(a): Background, Current Insights and Future Potential Therapies

Vascular health and risk management, 2021-01, Vol.17, p.527-542 [Peer Reviewed Journal]

2021 Handhle et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Handhle et al. 2021 Handhle et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S266244 ;PMID: 34526771

Full text available

8
The emerging role and clinical implication of human exonic circular RNA
Material Type:
Article
Add to My Research

The emerging role and clinical implication of human exonic circular RNA

RNA biology, 2017-08, Vol.14 (8), p.1000-1006 [Peer Reviewed Journal]

2017 Taylor & Francis Group, LLC 2017 ;2017 Taylor & Francis Group, LLC 2017 Taylor & Francis Group, LLC ;ISSN: 1547-6286 ;EISSN: 1555-8584 ;DOI: 10.1080/15476286.2016.1227904 ;PMID: 27588461

Full text available

9
Betanin as a multipath oxidative stress and inflammation modulator: a beetroot pigment with protective effects on cardiovascular disease pathogenesis
Material Type:
Article
Add to My Research

Betanin as a multipath oxidative stress and inflammation modulator: a beetroot pigment with protective effects on cardiovascular disease pathogenesis

Critical reviews in food science and nutrition, 2022-01, Vol.62 (2), p.539-554 [Peer Reviewed Journal]

2020 The Author(s). Published with license by Taylor and Francis Group, LLC 2020 ;2020 The Author(s). Published with license by Taylor and Francis Group, LLC. This work is licensed under the Creative Commons Attribution – Non-Commercial – No Derivatives License http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1040-8398 ;EISSN: 1549-7852 ;DOI: 10.1080/10408398.2020.1822277 ;PMID: 32997545

Digital Resources/Online E-Resources

10
Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
Material Type:
Article
Add to My Research

Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance

Vascular health and risk management, 2017-01, Vol.13, p.293-303 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Aghel et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s108874 ;PMID: 28831263

Full text available

11
Trends in cardiovascular diseases and associated risks in sub-Saharan Africa: a review of the evidence for Ghana, Nigeria, South Africa, Sudan and Tanzania
Material Type:
Article
Add to My Research

Trends in cardiovascular diseases and associated risks in sub-Saharan Africa: a review of the evidence for Ghana, Nigeria, South Africa, Sudan and Tanzania

The aging male, 2019-07, Vol.22 (3), p.169-176 [Peer Reviewed Journal]

2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 ;ISSN: 1368-5538 ;EISSN: 1473-0790 ;DOI: 10.1080/13685538.2019.1582621 ;PMID: 30879380

Digital Resources/Online E-Resources

12
Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action
Material Type:
Article
Add to My Research

Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action

Vascular health and risk management, 2021-01, Vol.17, p.739-769 [Peer Reviewed Journal]

2021 Zuraini et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 Zuraini et al. 2021 Zuraini et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S328096 ;PMID: 34858028

Full text available

13
Nonadherence to statins: individualized intervention strategies outside the pill box
Material Type:
Article
Add to My Research

Nonadherence to statins: individualized intervention strategies outside the pill box

Vascular health and risk management, 2018-01, Vol.14, p.91-102 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018 Lansberg et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S158641 ;PMID: 29872306

Full text available

14
Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients - a prospective observational study
Material Type:
Article
Add to My Research

Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients - a prospective observational study

Infectious diseases (London, England), 2021-02, Vol.53 (2), p.111-121 [Peer Reviewed Journal]

2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 2374-4235 ;EISSN: 2374-4243 ;DOI: 10.1080/23744235.2020.1840623 ;PMID: 33170050

Digital Resources/Online E-Resources

15
Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care
Material Type:
Article
Add to My Research

Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care

Vascular health and risk management, 2020-01, Vol.16, p.11-25 [Peer Reviewed Journal]

2020 Alonso et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Alonso et al. 2020 Alonso et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S192401 ;PMID: 32021224

Full text available

16
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes
Material Type:
Article
Add to My Research

Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes

Vascular health and risk management, 2013-01, Vol.9 (default), p.617-670 [Peer Reviewed Journal]

COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Kones. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2013 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S37119 ;PMID: 24174878

Full text available

17
Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases
Material Type:
Article
Add to My Research

Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases

International journal of nanomedicine, 2020-01, Vol.15, p.3741-3769 [Peer Reviewed Journal]

2020 Pala et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Pala et al. 2020 Pala et al. ;ISSN: 1178-2013 ;ISSN: 1176-9114 ;EISSN: 1178-2013 ;DOI: 10.2147/IJN.S250872 ;PMID: 32547026

Full text available

18
Platelet microvesicles in health and disease
Material Type:
Article
Add to My Research

Platelet microvesicles in health and disease

Platelets (Edinburgh), 2017-04, Vol.28 (3), p.214-221 [Peer Reviewed Journal]

ISSN: 0953-7104 ;EISSN: 1369-1635 ;DOI: 10.1080/09537104.2016.1265924 ;PMID: 28102737

Digital Resources/Online E-Resources

19
Archaebiotics: Proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease
Material Type:
Article
Add to My Research

Archaebiotics: Proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease

Gut microbes, 2014-01, Vol.5 (1), p.5-10 [Peer Reviewed Journal]

Copyright © 2014 Landes Bioscience 2014 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1949-0976 ;EISSN: 1949-0984 ;DOI: 10.4161/gmic.26749 ;PMID: 24247281

Full text available

20
Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States
Material Type:
Article
Add to My Research

Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States

Current medical research and opinion, 2022-11, Vol.38 (11), p.1785-1795 [Peer Reviewed Journal]

2022 Eli Lilly and Company. Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2022.2085962 ;PMID: 35758147

Digital Resources/Online E-Resources

Results 1 - 20 of 6,785  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1988  (18)
  2. 1988 To 1996  (125)
  3. 1997 To 2005  (386)
  4. 2006 To 2015  (2,162)
  5. After 2015  (4,095)
  6. More options open sub menu

Resource Type 

  1. Articles  (6,775)
  2. Reports  (5)
  3. Reviews  (5)
  4. More options open sub menu

Subject 

  1. Science & Technology  (5,961)
  2. Life Sciences & Biomedicine  (5,921)
  3. Cardiovascular Disease  (4,349)
  4. Humans  (3,112)
  5. Original Research  (2,632)
  6. Risk Factors  (2,481)
  7. Cardiovascular Diseases  (1,835)
  8. Female  (1,794)
  9. Male  (1,761)
  10. Diabetes  (1,615)
  11. Hypertension  (1,572)
  12. Mortality  (1,415)
  13. Middle Aged  (1,362)
  14. Patients  (1,267)
  15. Aged  (1,202)
  16. Cardiovascular System & Cardiology  (1,088)
  17. Blood Pressure  (1,080)
  18. Health Aspects  (1,039)
  19. Review  (1,017)
  20. Medical Research  (975)
  21. More options open sub menu

Language 

  1. English  (6,784)
  2. Japanese  (450)
  3. Norwegian  (17)
  4. French  (2)
  5. Spanish  (2)
  6. Italian  (1)
  7. BokmÃ¥l, Norwegian  (1)
  8. German  (1)
  9. More options open sub menu

Searching Remote Databases, Please Wait